Cervical Cancer 2 Flashcards
What is cervical cancer
Cervical cancer is the second most common type of cancer exclusive to women worldwide. after Breast and before Endometrial and Ovarian
most often squamous cell carcinomas that arise from infection with a high-risk human papillomavirus (HPV) serotype.
preceded by cervical intraepithelial neoplasia (CIN), which can be detected via Pap smear
Usually dg at 48 y/o
What are the most common cancers of the female reproductive system
1.cervical
2Endometrial.
3.Ovarian
Mortality
- Ovarian
- Cervical
- Endometrial
Aetiology of cervical cancer
Infection with high-risk HPV:16 & 8
Squamous cell carcinoma 15-20%16 (exocervical implantation) more common
75-80% Adenocarcinoma 18 (endocervical implantation)
RF
Early onset of sexual activity/multiple sexual partners (strongest RF)
High parity
Immunosuppression (very common in AIDS d/2 HIV infection)
History of sexually transmitted infections (herpes simplex, chlamydia)
Cigarette smoking /second-hand smoke (for squamous cell cancer only)
Oral contraceptives >5years (possibly d/2 increased sexual activity)
Low socioeconomic status (poor access to Pap smears)
In-utero exposure to diethylstilbestrol (DES) ( used in 1940’s to prevent miscarriage )
Pathogenesis of cervical cancer
Sex W/ HPV infected donny
Implantation of HPV in TRANSITIONAL ZONE
Production of oncoproteins
1) E6 → inhibiton of p53 (tumour suppressor)→ inhibition of intrinsic apoptotic pathway
2) E7 →Inhibits retinoblastoma protein (tumour suppressor)→ increased activity of E2F-family of transcription factors
Either 1) implantation in squamous cells -squamaous dysplasia- CIN(1,2&3) -Doc as Low grade SIL(CIN1) OR high grade SIL(CN2/3) -CIS -invasive SCC OR 1)implantation into glandular cells -differentiation-dysplasia- -glandular intro epithelial lesion -invasive glandular carcinoma
Sx of cervical cancer
Patients are usually asymptomatic in early stages.
Symptoms commonly first appear in advanced disease.
-Abnormal vaginal bleeding: menometrorrhagia, postcoital spotting
-Abnormal vaginal discharge: blood-stained or purulent w/ bad smell
-Cervical ulceration
Late symptoms
-Mass effect
#Hydronephrosis: d/2 compression of the ureters
#Swelling of lower limbs d/2 compression of pelvic veins/lymphatics
-Features of disseminated disease: #lymphadenopathy of: paraaortic lymph nodes & lymph nodes along the external iliac artery #metastatic pain of: liver, lungs, pelvic bones and vertebra,and brain.
Most patients that do not undergo therapy die before distant spread occurs d/2 Prenal metastasis and RENAL FAILURE
Always consider cervical cancer as a cause of postcoital bleeding!
Dg of cervical cancer
Pap smear & histology w/ Bethesda system
-scrape areas from transitional zone
-
HPV test
-women > 30 years of age alongside PAP smear
-PCR: detection of HPV DNA
Colposcopy: 3% acetic acid stains normal squamous cells brown d/2 glycogen
-unscrapabable leukoplakia(No glycogen) in & around TZ
Conization : excision of a cone of cervical tissue that contains TZ with Loop Electroexcisional Procedure
Complications of dg procedures in cervical CANCER
Intraoperative or postoperative bleeding
Cervical stenosis causing infertility
Cervical insufficiency during pregnancy
Infection, uterine perforation
complications of cervical cancer
1)direct complications of the cancer
-hydronephrosis
-RF
-Fistula formation
#recto-vaginal
#vesico-vaginal
-cancer anorexia syndrome
-lower limb oedema
2) complications of radiotherapy
- vaginal stenosis
- radiogenic cystits
prevention of cervical cancer consists of ?
primary prophylaxis
1) HPV immunization
2) condoms (partial proph as skin to skin can transmit HPV)
3) abstinence
secondary prophylaxis
- screening via pap smear
- all women aged 21–65 should participat
what are the indications of HPV vaccination
Women: 9–26 years of age
Men: 9–21 years of age
what are the priniciples of PAP smear screening
21–29 years: Pap smear every 3 years
30–65 years: Pap smear every 3 years OR Pap smear + HPV test every 5 years
> 65 years: no testing required if previous testing was negative
women with DES exposure/ HIV require continued screening